Safety Could Differentiate Nkarta’s CAR-NK Cell Therapy

Allogeneic Therapy Can Be Re-Dosed

 
• By Andrew McConaghie
  
NK Cell
Harnessing the power of natural killer cells could prove to be superior to CAR-Ts, especially on safety. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip